Lexicon Pharmaceuticals, Inc.

Company: Lexicon Pharmaceuticals, Inc.
Ticker: LXRX

Submit Your Information

If you suffered a loss on your Lexicon Pharmaceuticals, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filling out this form mean you have joined any lawsuit.

First Name*

Last Name*

Email*

Phone*

City

State

Country

Total # of shares

First Purchase Date

Last Purchase Date

Estimated Loss Range

Check here if you still hold any shares.

Check here if you are a current or former employee of the company.

Check here if you purchased any shares before

Additional Comments

Background

On February 28, 2022, Lexicon issued a press release announcing the voluntary withdrawal of the Company’s New Drug Application for its glucose regulation drug, sotagliflozin, in order to correct a technical issue with the submission that had been recently identified by the Company.

On this news, Lexicon’s stock price fell $0.78, or 27.37%, to close at $2.07 per share on February 28, 2022, thereby injuring investors.

Submit Your Information